Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP)
与化疗相比,免疫疗法在任何治疗阶段都能提高晚期转移性非小细胞肺癌(NSCLC)患者的生存率(Quijote-CLICaP)。
期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.13272
Ruiz-Patiño, Alejandro; Arrieta, Oscar; Cardona, Andrés F; Martín, Claudio; Raez, Luis E; Zatarain-Barrón, Zyanya L; Barrón, Feliciano; Ricaurte, Luisa; Bravo-Garzón, María A; Mas, Luis; Corrales, Luis; Rojas, Leonardo; Lupinacci, Lorena; Perazzo, Florencia; Bas, Carlos; Carranza, Omar; Puparelli, Carmen; Rizzo, Manglio; Ruiz, Rossana; Rolfo, Christian; Archila, Pilar; Rodríguez, July; Sotelo, Carolina; Vargas, Carlos; Carranza, Hernán; Otero, Jorge; Pino, Luis E; Ortíz, Carlos; Laguado, Paola; Rosell, Rafael